ASMB has been in the news 500% more than usual
Dec 18, 2025, 5:32 PM
4.28%
What does ASMB do
Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
ASMB has been in the news recently: Assembly Biosciences has appointed Bridget Hopkins as Europe CEO to focus on growth and improving client relationships in the region. The company aims to navigate the complexities of Europe's media landscape under her leadership.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.